Physician profile
Yi Lee
NPI 1700401254
$360.10
in general payments reported to CMS, 2019-2025
6 companies · $26.62 in 2025
The $26.62 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $333 · 2025: $26.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $26.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $26.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Foundation Medicine, INC. | $229.00 | 2022 | |
| Karyopharm Therapeutics INC. | $47.78 | 2022 | |
| Syndax Pharmaceuticals, INC. | $26.62 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.81 | 2022 | |
| Lilly USA, LLC | $18.75 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.14 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yi Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.